Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Incannex Healthcare (IXHL) Shares Outstanding (Weighted Average) (2023 - 2025)

Historic Shares Outstanding (Weighted Average) for Incannex Healthcare (IXHL) over the last 3 years, with Q4 2025 value amounting to $40.0.

  • Incannex Healthcare's Shares Outstanding (Weighted Average) fell 9384.62% to $40.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $40.0, marking a year-over-year decrease of 9384.62%. This contributed to the annual value of $34.5 million for FY2025, which is 11314.99% up from last year.
  • Latest data reveals that Incannex Healthcare reported Shares Outstanding (Weighted Average) of $40.0 as of Q4 2025, which was down 9384.62% from $310.3 million recorded in Q3 2025.
  • Over the past 5 years, Incannex Healthcare's Shares Outstanding (Weighted Average) peaked at $310.3 million during Q3 2025, and registered a low of $40.0 during Q4 2025.
  • For the 3-year period, Incannex Healthcare's Shares Outstanding (Weighted Average) averaged around $44.6 million, with its median value being $16.0 million (2023).
  • In the last 5 years, Incannex Healthcare's Shares Outstanding (Weighted Average) crashed by 9999.59% in 2024 and then soared by 165884.27% in 2025.
  • Incannex Healthcare's Shares Outstanding (Weighted Average) (Quarter) stood at $15.9 million in 2023, then crashed by 100.0% to $650.0 in 2024, then crashed by 93.85% to $40.0 in 2025.
  • Its Shares Outstanding (Weighted Average) was $40.0 in Q4 2025, compared to $310.3 million in Q3 2025 and $34.5 million in Q2 2025.